Livongo Health (NASDAQ:LVGO) Now Covered by Analysts at Needham & Company LLC
Needham & Company LLC initiated coverage on shares of Livongo Health (NASDAQ:LVGO) in a report issued on Monday morning, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $42.00 target price on the stock.
LVGO has been the subject of a number of other reports. Leerink Swann started coverage on shares of Livongo Health in a report on Monday. They issued an outperform rating and a $50.00 price target for the company. Chardan Capital started coverage on shares of Livongo Health in a report on Friday, August 16th. They issued a neutral rating and a $40.00 price target for the company. Finally, Piper Jaffray Companies started coverage on shares of Livongo Health in a report on Monday. They issued an overweight rating and a $40.00 price target for the company. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Livongo Health presently has a consensus rating of Buy and an average target price of $44.20.
Shares of Livongo Health stock opened at $35.42 on Monday. Livongo Health has a fifty-two week low of $31.60 and a fifty-two week high of $45.68.
About Livongo Health
Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.
Recommended Story: Using the New Google Finance Tool
Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.